15 January 2021>: Clinical Research
Wide-Field Fluorescein Angiography in the Diagnosis and Management of Retinal Vein Occlusion: A Retrospective Single-Center Study
Monika J. Turczyńska ABCDEF , Przemysław Krajewski CEF , Joanna E. Brydak-Godowska AF*DOI: 10.12659/MSM.927782
Med Sci Monit 2021; 27:e927782
Table 3 Branch retinal vein occlusion. Involvement of specific retinal vein branches, and number and percentage of patients with ischemic and non-ischemic occlusions.
BRVO localization (a total of 41 patients) | Type of occlusion, number and percentage of patients affected |
---|---|
Superior temporal branch (24/41 patients, 58.3%) | Ischemic (8/24, 75%)Non-ischemic (5/24, 20.8%)Non-ischemic → ischemic (1/24, 4.2%) |
Inferior temporal branch (15/41, 36.6%) | Ischemic (6/15, 40%)Non-ischemic (7/15, 46.7%)Non-ischemic → ischemic (2/15, 13.3%) |
Inferior nasal branch (1/41, 2.4%) | Ischemic |
Superior nasal branch (0/41, 0%) | |
Inferior temporal branch and large branch above the optic disc (1/41, 2.4%) | Ischemic |